Edwards Lifesciences
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.About EW
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care.
EW Key Statistics
Stock Snapshot
Edwards Lifesciences(EW) stock is priced at $85.21, giving the company a market capitalization of 49.11B. It carries a P/E multiple of 50.56.
On 2026-10-10, Edwards Lifesciences(EW) stock moved within a range of $83.22 to $85.34. With shares now at $85.21, the stock is trading +2.4% above its intraday low and -0.2% below the session's peak.
Trading volume for Edwards Lifesciences(EW) stock has reached 3.84M, versus its average volume of 3.76M.
The stock's 52-week range extends from a low of $72.30 to a high of $96.29.
The stock's 52-week range extends from a low of $72.30 to a high of $96.29.
EW News
...
Edwards Lifesciences reported that the FDA has approved the AUTUS Size-Adjustable Valve, a pediatric-focused surgical pulmonary valve that can be expanded as ch...
Barclays analyst Christopher Pasquale initiated coverage of Edwards Lifesciences (EW) with an Overweight rating and $110 price target The firm rolled out covera...
Analyst ratings
77%
of 31 ratingsMore EW News
Advertisement FDA approval of AUTUS puts Edwards Lifesciences in focus Edwards Lifesciences (EW) just received U.S. Food and Drug Administration approval for...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.